Moberg Pharma AB (OSTO:MOB) Cyclically Adjusted Book per Share: kr135.19 (As of Mar. 2026)


OSTO:MOB Moberg Pharma AB OSTO:MOB
60 GF Score
Price kr9.45
GF Value kr12.45
Valuation Modestly Undervalued
! 1 Warning Sign
View Full Analysis

What is Moberg Pharma AB Cyclically Adjusted Book per Share?

Moberg Pharma AB OSTO:MOB +0.21% 60 Cyclically Adjusted Book per Share is kr135.19 as of Mar. 2026. GuruFocus rates OSTO:MOB with a GF Score™ of 60/100 and a GF Value™ of kr12.45 (Modestly Undervalued). The stock has 1 warning sign investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Moberg Pharma AB's adjusted book value per share for the three months ended in Mar. 2026 was kr14.152. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is kr135.19 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Moberg Pharma AB's average Cyclically Adjusted Book Growth Rate was -10.60% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 0.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Moberg Pharma AB was 0.80% per year. The lowest was 0.80% per year. And the median was 0.80% per year.

As of today (2026-07-06), Moberg Pharma AB's current stock price is kr9.45. Moberg Pharma AB's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 was kr135.19. Moberg Pharma AB's Cyclically Adjusted PB Ratio of today is 0.07.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Moberg Pharma AB was 3.20. The lowest was 0.03. And the median was 0.09.


Moberg Pharma AB  (OSTO:MOB) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Moberg Pharma AB's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=9.45/135.19
=0.07

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Moberg Pharma AB was 3.20. The lowest was 0.03. And the median was 0.09.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Moberg Pharma AB Cyclically Adjusted Book per Share Related Terms


Moberg Pharma AB Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Moberg Pharma AB's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Moberg Pharma AB Cyclically Adjusted Book per Share Chart

Moberg Pharma AB Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 151.37 167.00 165.40 155.04

Moberg Pharma AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 151.21 148.35 143.80 139.45 135.19

OSTO:MOB vs ZTS, UTHR: Cyclically Adjusted Book per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Moberg Pharma AB's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Moberg Pharma AB Cyclically Adjusted PB Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Moberg Pharma AB's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Moberg Pharma AB's Cyclically Adjusted PB Ratio falls into.


OSTO:MOB
60GF Score
Moberg Pharma AB OSTO:MOB
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Moberg Pharma AB Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Moberg Pharma AB's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book= Book Value per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=14.152/133.5600*133.5600
=14.152

Current CPI (Mar. 2026) = 133.5600.

Moberg Pharma AB Quarterly Data

Book Value per Share CPI Adj_Book
201512 141.242 100.276 188.124
201603 137.159 100.751 181.824
201606 151.639 101.019 200.485
201609 158.336 101.138 209.095
201612 183.598 102.022 240.355
201703 181.345 102.022 237.405
201706 174.894 102.752 227.332
201709 175.983 103.279 227.581
201712 180.290 103.793 231.996
201803 182.358 103.962 234.276
201806 186.687 104.875 237.750
201809 189.289 105.679 239.229
201812 191.003 105.912 240.864
201903 358.902 105.886 452.703
201906 350.980 106.742 439.163
201909 372.126 107.214 463.570
202003 101.412 106.563 127.104
202006 0.000 107.498 0.000
202009 98.031 107.635 121.643
202103 65.048 108.360 80.176
202106 64.459 108.928 79.035
202109 63.961 110.338 77.422
202112 63.430 112.486 75.314
202203 62.316 114.825 72.483
202206 36.648 118.384 41.346
202209 36.374 122.296 39.724
202212 36.200 126.365 38.261
202303 35.894 127.042 37.736
202306 35.669 129.407 36.814
202309 22.058 130.224 22.623
202312 21.842 131.912 22.115
202403 21.632 132.205 21.854
202406 20.271 132.716 20.400
202409 19.889 132.304 20.078
202412 14.709 132.987 14.772
202503 14.681 132.825 14.762
202506 14.462 133.699 14.447
202509 14.402 133.480 14.411
202512 14.153 133.390 14.171
202603 14.152 133.560 14.152

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of kr135.19 mean?
Moberg Pharma AB (OSTO:MOB) has a Cyclically Adjusted Book per Share of kr135.19 as of Mar. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Moberg Pharma AB and its competitors.
Is Moberg Pharma AB's Cyclically Adjusted Book per Share too high?
Moberg Pharma AB's current Cyclically Adjusted Book per Share is kr135.19. Overall, Moberg Pharma AB has a GF Score™ of 60/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Moberg Pharma AB's Cyclically Adjusted Book per Share compare to ZTS and UTHR?
Moberg Pharma AB's Cyclically Adjusted Book per Share of kr135.19 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Drug Manufacturers company?
A good Cyclically Adjusted Book per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Moberg Pharma AB and its competitors. Moberg Pharma AB's current Cyclically Adjusted Book per Share is kr135.19. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Moberg Pharma AB stock overvalued right now?
Based on GuruFocus' analysis, Moberg Pharma AB (OSTO:MOB) is currently considered Modestly Undervalued. The stock's GF Value™ is kr12.45, compared to a current price of kr9.45 — trading 24.1% below its estimated fair value. The current Cyclically Adjusted Book per Share is kr135.19. Moberg Pharma AB's overall GF Score™ is 60/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Moberg Pharma AB (OSTO:MOB), the current Cyclically Adjusted Book per Share is kr135.19 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Moberg Pharma AB (OSTO:MOB) Overvalued in 2026?

Based on GuruFocus' analysis, Moberg Pharma AB stock appears to be undervalued. The current stock price of kr9.45 is trading 24.1% below its estimated GF Value™ of kr12.45. GuruFocus considers Moberg Pharma AB to be Modestly Undervalued.

Key valuation signals for OSTO:MOB:

  • Cyclically Adjusted Book per Share: kr135.19
  • GF Value™: kr12.45 vs. price of kr9.45 (24.1% below fair value)
  • GF Score™: 60/100 with 1 warning sign

No single metric tells the full story. See the OSTO:MOB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Moberg Pharma AB Business Description

Other Exchanges MBGPF:USA
Address Gustavslundsvagen 42, 5th Floor, Bromma, Stockholm, SWE, SE-167 51
Moberg Pharma AB is a Swedish pharmaceutical company which develops and commercializes proprietary pharmaceuticals based on proven substances. The company develops and markets consumer healthcare products that relieve pain and treat skin conditions, mainly nail fungus. The Company's main product, MOB-015, is a novel topical treatment for onychomycosis It has a single operating segment, the development, and commercialization of medical products. Its geographic areas are Europe, the Americas, and Rest of the world.
60GF Score

Get the complete analysis for OSTO:MOB

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr9.45
Price
kr12.45
GF Value